The Lancet Diabetes & Endocrinology in conversation with

Margherita Pizzato on the global epidemiological landscape of thyroid cancer


Listen Later

Margherita Pizzato talks with The Lancet Diabetes & Endocrinology about the global epidemiological landscape of thyroid cancer based on GLOBOCAN estimates in 2020.

Read the full article:
The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

...more
View all episodesView all episodes
Download on the App Store

The Lancet Diabetes & Endocrinology in conversation withBy The Lancet Group

  • 5
  • 5
  • 5
  • 5
  • 5

5

1 ratings


More shows like The Lancet Diabetes & Endocrinology in conversation with

View all
NEJM This Week by NEJM Group

NEJM This Week

323 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

506 Listeners

Being Well with Forrest Hanson and Dr. Rick Hanson by Rick Hanson, Ph.D., Forrest Hanson

Being Well with Forrest Hanson and Dr. Rick Hanson

2,474 Listeners

The Peter Attia Drive by Peter Attia, MD

The Peter Attia Drive

8,098 Listeners

The Lancet Voice by The Lancet Group

The Lancet Voice

23 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Global Health in conversation with by The Lancet Group

The Lancet Global Health in conversation with

2 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

1 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

2 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

0 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

0 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Lancet Regional Health in conversation with by The Lancet Group

The Lancet Regional Health in conversation with

0 Listeners

The Lancet Regional Health Americas in conversation with by The Lancet Group

The Lancet Regional Health Americas in conversation with

0 Listeners

The Lancet Primary Care in conversation with by The Lancet Group

The Lancet Primary Care in conversation with

0 Listeners